IDXXbusinesswire

IDEXX Announces CEO Succession

Summary

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the promotion of Michael (Mike) Erickson, PhD, to President and Chief Executive Officer, effective May 12, 2026, at which time Jonathan (Jay) Mazelsky, President and CEO, will transition to the role of Executive Chair of IDEXX’s Board of Directors (the “Board”). Mr. Mazelsky has announced his intention to retire from the Company immediately following the Comp

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on January 13, 2026 by businesswire